PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 19, 2026JGH Open0 citationsOpen Access

Magnetic Resonance Enterography Predicts Long‐Term Outcomes in Crohn's Disease: A Systematic Review and Meta‐Analysis

View Full Paper
SWShanshan WuAnhui Medical UniversityJYJiayi YangWuxi People's HospitalSJSeniu JizhiChengdu Military General Hospital

Key Points

  • The aim is to evaluate how effectively magnetic resonance enterography predicts long-term outcomes such as surgery and hospitalization in Crohn's disease patients.
  • Conducted systematic review and meta-analysis of 16 studies
  • Included adult Crohn's disease patients with at least 12 months of follow-up
  • Analyzed baseline MRE phenotypes and post-treatment transmural healing
  • Calculated hazard ratios to assess risks associated with MRE findings and outcomes.
  • Baseline penetrating lesions increased surgical risk (HR = 1.62) and hospitalization risk (HR = 1.34)
  • Stricturing lesions were similarly linked to a higher surgical risk (HR = 1.65)
  • Achieving transmural healing significantly reduced risks of surgery (HR = 0.55), hospitalization (HR = 0.54), and treatment escalation (HR = 0.51)
  • Transmural healing yielded greater risk reduction compared to mucosal healing alone.

Abstract

ABSTRACT Background and Aims Crohn's disease (CD) is characterized by chronic transmural inflammation, which often leads to bowel damage. While mucosal healing (MH) is an established treatment target, transmural healing (TH) has emerged as a more comprehensive goal. Magnetic resonance enterography (MRE) provides excellent soft‐tissue resolution for assessing TH. This meta‐analysis evaluates the prognostic value of MRE in predicting surgery, hospitalization, and treatment escalation in adults with CD. Methods A total of 16 studies involving adult CD patients with ≥ 12 months of follow‐up (with a mean duration of 4.42 ± 3.90 years) were included if they incorporated pre‐ and posttreatment MRE, reported baseline MRE phenotypes (e.g., penetrating/stenosing lesions), and documented posttreatment TH. Hazard ratios (HRs) were used to compare associations between baseline MRE features, TH achievement, and long‐term outcomes. Results Baseline MRE‐defined penetrating lesions were associated with increased risks of surgery (HR = 1.62, 95% CI: 1.37–1.91, p < 0.00001) and hospitalization (HR = 1.34, 95% CI: 1.18–1.53, p < 0.0001). Similarly, stricturing lesions were associated with an elevated risk of surgery (HR = 1.65, 95% CI: 1.39–1.96, p < 0.00001). Achieving TH was linked to lower risks of surgery (HR = 0.55, 95% CI: 0.44–0.68, p < 0.00001), hospitalization (HR = 0.54, 95% CI: 0.45–0.64, p < 0.00001), and treatment escalation (HR = 0.51, 95% CI: 0.46–0.57, p < 0.00001). Notably, TH achieved significantly greater risk reduction than MH alone, as evidenced by two direct comparative studies of these two treatment targets (HR = 0.28 and 0.26, respectively). Conclusion MRE‐identified penetrating/stenosing lesions at baseline predict higher risks of surgery and hospitalization. Conversely, TH achievement was associated with a marked reduction in adverse outcomes. Incorporating MRE into CD management facilitates early identification of high‐risk patients for timely treatment intensification, thereby supporting personalized therapeutic strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wu et al. (2026) studied this question.

synapsesocial.com/papers/69e47282010ef96374d8e7d8https://doi.org/10.1002/jgh3.70408
Ask AI
Helpful
Bookmark
Share
View Full Paper